Welcome to our dedicated page for Crocs SEC filings (Ticker: CROX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Comfort made profitable. Crocs Inc. may be famous for Croslite� clogs, but its SEC disclosures reveal much more—how seasonal demand, Jibbitz� accessories, and direct-to-consumer growth translate into cash flow. If you have ever searched “Crocs SEC filings explained simply� or wondered which regions still drive double-digit sales, this is the place to start.
Stock Titan layers AI-powered summaries on every document, so understanding Crocs SEC documents with AI takes minutes, not hours. The latest Crocs annual report 10-K simplified highlights sourcing risks in Vietnam, while the Crocs quarterly earnings report 10-Q filing flags margin shifts when resin prices spike. Need real-time alerts? Our dashboard streams Crocs Form 4 insider transactions real-time, letting you monitor executive stock moves minutes after they hit EDGAR.
All filing types are covered and connected to practical questions investors ask:
- Form 4 � Track insider buying and selling with the exact option strike prices in the �Crocs insider trading Form 4 transactions� feed.
- 8-K � Material event reports, from CEO succession to new collaboration launches, appear under �Crocs 8-K material events explained�.
- Proxy Statement � Dive into �Crocs proxy statement executive compensation� to see how the board ties bonuses to inventory turns.
- 10-Q & 10-K � Side-by-side revenue by geography, gross-margin bridges, and Crocs earnings report filing analysis, all distilled by AI.
Whether you’re benchmarking footwear peers or timing trades around new model launches, Stock Titan delivers comprehensive coverage, expert context, and AI-driven clarity—so you can act on Crocs data before the market laces up.
Crocs, Inc. reporting person Susan L. Healy, EVP and Chief Financial Officer, purchased 2,000 shares of Crocs common stock on 08/12/2025 at $76.56 per share. After the purchase she beneficially owns 50,078 shares. The Form 4 was signed by an attorney-in-fact on 08/14/2025. No derivative transactions or additional remarks are reported.
John B. Replogle, a director of Crocs, Inc. (CROX), reported purchases of company stock on 08/08/2025. He acquired 336 shares at a weighted-average price of $76.302 and 2,925 shares at a weighted-average price of $76.734, for a total of 3,261 shares added to his holdings. The filings show beneficial ownership of 12,492 shares after the first reported purchase and 15,417 shares following the second reported purchase.
The report discloses that the purchases were executed in multiple transactions with price ranges of $75.550 to $76.426 and $76.595 to $76.750 for the two groups of shares, respectively, and the filer's footnotes offer to provide a breakdown of shares purchased at each price upon request.
WIT Partners Advisory Pte. Ltd., a Singapore investment adviser, reports beneficial ownership of 2,852,280 shares of Crocs, Inc. common stock, representing 5.19% of the class. The filing states the reporting person has sole voting power and sole dispositive power over those shares and reports no shared voting or dispositive power.
The document is submitted as a Schedule 13G disclosure and includes certifications that the foreign regulatory scheme applicable to the reporting person is substantially comparable to the U.S. scheme and that the securities were not acquired to change or influence control of the issuer.
FAQ
What is the current stock price of Crocs (CROX)?
What is the market cap of Crocs (CROX)?
